2v61 | pdb_00002v61
STRUCTURE OF HUMAN MAO B IN COMPLEX WITH THE SELECTIVE INHIBITOR 7-(3-CHLOROBENZYLOXY)-4-(METHYLAMINO)METHYL-COUMARIN
| |||||||||||||
| 2v61, resolution 1.70Å | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sites: | AC1, AC2, AC3 and AC4 | ||||||||||||
| Ligands: | C18, FAD | ||||||||||||
| Activity: | Amine oxidase (flavin-containing), with EC number 1.4.3.4 | ||||||||||||
| Related: | 1GOS, 1H8R, 1OJ9, 1OJA, 1OJB, 1OJC, 1OJD, 1S2Q, 1S2Y, 1S3B, 1S3E, 2BK3, 2BK4, 2BK5, 2BYB, 2C64, 2C65, 2C66, 2C67, 2C70, 2C72, 2C73, 2C75, 2C76, 2V5Z, 2V60
| ||||||||||||
| Resources: | FirstGlance, OCA, PDBsum, RCSB | ||||||||||||
| Coordinates: | save as pdb, mmCIF, xml | ||||||||||||
Overview
Structures of human monoamine oxidase B (MAO B) in complex with safinamide and two coumarin derivatives, all sharing a common benzyloxy substituent, were determined by X-ray crystallography. These compounds competitively inhibit MAO B with Ki values in the 0.1-0.5 microM range that are 30-700-fold lower than those observed with MAO A. The inhibitors bind noncovalently to MAO B, occupying both the entrance and the substrate cavities and showing a similarly oriented benzyloxy substituent.
About this Structure
2V61 is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.
Reference
Structures of human monoamine oxidase B complexes with selective noncovalent inhibitors: safinamide and coumarin analogs., Binda C, Wang J, Pisani L, Caccia C, Carotti A, Salvati P, Edmondson DE, Mattevi A, J Med Chem. 2007 Nov 15;50(23):5848-52. Epub 2007 Oct 4. PMID:17915852
Page seeded by OCA on Mon Mar 31 05:08:47 2008
Proteopedia Page Contributors and Editors (what is this?)
- Pages with broken file links
- Amine oxidase (flavin-containing)
- Homo sapiens
- Single protein
- Binda, C.
- Caccia, C.
- Carotti, A.
- Edmondson, D E.
- Mattevi, A.
- Pisani, L.
- Salvati, P.
- Wang, J.
- Fad
- Flavoprotein
- Human mao b structure
- Membrane
- Mitochondrion
- Neuroprotection
- Oxidoreductase
- Parkinson's disease
- Reversible inhibitor binding
- Safinamide
- Transmembrane